HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor lysis syndrome in a multiple myeloma treated with thalidomide.

AuthorsN Fuente, J M Mañe, R Barcelo, A Muñoz, T Perez-Hoyos, G Lopez-Vivanco
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 15 Issue 3 Pg. 537 (Mar 2004) ISSN: 0923-7534 [Print] England
PMID14998862 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Thalidomide
Topics
  • Antineoplastic Agents (adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma (drug therapy)
  • Thalidomide (adverse effects)
  • Tumor Lysis Syndrome (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: